메뉴 건너뛰기




Volumn 6, Issue 5, 2007, Pages 533-545

Off-label use of antipsychotics: Are we mad?

Author keywords

Antipsychotic; Off label; Prescribing

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PIMOZIDE; PLACEBO; PROLACTIN; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; ZOTEPINE;

EID: 35349024967     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.5.533     Document Type: Review
Times cited : (31)

References (99)
  • 2
    • 3843085422 scopus 로고    scopus 로고
    • Indian Medical Association wants off-label prescribing
    • NO AUTHORS LISTED: Indian Medical Association wants off-label prescribing. BMJ (2004) 328:974.
    • (2004) BMJ , vol.328 , pp. 974
    • AUTHORS LISTED, N.1
  • 3
    • 38649095345 scopus 로고    scopus 로고
    • Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice
    • ROYAL COLLEGE OF PSYCHIATRISTS:, CR142. Royal College of Psychiatrists London, UK
    • ROYAL COLLEGE OF PSYCHIATRISTS: Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice. College Report CR142. Royal College of Psychiatrists London, UK (2007).
    • (2007) College Report
  • 4
    • 0032853345 scopus 로고    scopus 로고
    • Off-label prescribing: Legal implications
    • HENRY V: Off-label prescribing: legal implications. J. Legal Med. (1999) 20:365-383.
    • (1999) J. Legal Med , vol.20 , pp. 365-383
    • HENRY, V.1
  • 5
    • 0029039326 scopus 로고
    • Risk: Benefit analysis of drugs in practice
    • NO AUTHORS LISTED: Risk: benefit analysis of drugs in practice. Drug Ther. Bull. (1995) 5:33-35.
    • (1995) Drug Ther. Bull , vol.5 , pp. 33-35
    • AUTHORS LISTED, N.1
  • 6
    • 0031763286 scopus 로고    scopus 로고
    • Prescriptions, licences and evidence
    • HEALY D, NUTT D: Prescriptions, licences and evidence. Psychiatr. Bull. (1998) 22:680-684.
    • (1998) Psychiatr. Bull , vol.22 , pp. 680-684
    • HEALY, D.1    NUTT, D.2
  • 8
    • 31744433268 scopus 로고    scopus 로고
    • Off-label prescribing by psychiatrists
    • HODGSON R, BELGAMWAR R: Off-label prescribing by psychiatrists. Psychiatr. Bull. (2006) 30:55-57.
    • (2006) Psychiatr. Bull , vol.30 , pp. 55-57
    • HODGSON, R.1    BELGAMWAR, R.2
  • 9
    • 0037160179 scopus 로고    scopus 로고
    • An analysis of off-licence prescribing in psychiatric medicine
    • DOUGLAS-HALL P, FULLER A, GILL-BANHAM S: An analysis of off-licence prescribing in psychiatric medicine. Pharm. J. (2001) 267:890-891.
    • (2001) Pharm. J , vol.267 , pp. 890-891
    • DOUGLAS-HALL, P.1    FULLER, A.2    GILL-BANHAM, S.3
  • 10
    • 0035286571 scopus 로고    scopus 로고
    • From clinical trials to real-world practice: Use of atypical antipsychotic medication nationally in the Department of Veterans Affairs
    • ROSENHECK R, LESLIE D, SERNYAK M: From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Med. Care (2001) 39:302-308.
    • (2001) Med. Care , vol.39 , pp. 302-308
    • ROSENHECK, R.1    LESLIE, D.2    SERNYAK, M.3
  • 11
    • 17644392108 scopus 로고    scopus 로고
    • Antipsychotic prescribing pattern among Italian general practitioners: A population-based study during the years 1999-2002
    • TRIFIRÒ G, SPINA E, BRIGNOLI O et al.: Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur. J. Clin. Pharmacol. (2005) 61:47-53.
    • (2005) Eur. J. Clin. Pharmacol , vol.61 , pp. 47-53
    • TRIFIRÒ, G.1    SPINA, E.2    BRIGNOLI, O.3
  • 12
    • 1642564419 scopus 로고    scopus 로고
    • Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice
    • BARBUI C, CIUNA A, NOSÉ M et al.: Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice. Acta Psych. Scand. (2004) 109:275-278.
    • (2004) Acta Psych. Scand , vol.109 , pp. 275-278
    • BARBUI, C.1    CIUNA, A.2    NOSÉ, M.3
  • 14
    • 0038169046 scopus 로고    scopus 로고
    • Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997
    • LINDESAY J, MATTHEWS R, JAGGER C: Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int. J. Geriatr. Psychiatry (2003) 18:511-519.
    • (2003) Int. J. Geriatr. Psychiatry , vol.18 , pp. 511-519
    • LINDESAY, J.1    MATTHEWS, R.2    JAGGER, C.3
  • 16
    • 29944447802 scopus 로고    scopus 로고
    • Why and how antipsychotic drugs are used in 40 Sydney nursing homes
    • SNOWDON J, DAY S, BAKER W: Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int. J. Geriatr. Psychiatry (2005) 20:1146-1152.
    • (2005) Int. J. Geriatr. Psychiatry , vol.20 , pp. 1146-1152
    • SNOWDON, J.1    DAY, S.2    BAKER, W.3
  • 18
    • 0242468514 scopus 로고    scopus 로고
    • Prescribing practices of community child and adolescent psychiatrists
    • DOERRY U, KENT L: Prescribing practices of community child and adolescent psychiatrists. Psychiatr. Bull. (2003) 27:407-410.
    • (2003) Psychiatr. Bull , vol.27 , pp. 407-410
    • DOERRY, U.1    KENT, L.2
  • 19
    • 19344378756 scopus 로고    scopus 로고
    • Trends in the use of typical and atypical antipsychotics in children and adolescents
    • PATEL NC, CRISMON ML, HOAGWOOD K et al.: Trends in the use of typical and atypical antipsychotics in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44:548-556.
    • (2005) J. Am. Acad. Child Adolesc. Psychiatry , vol.44 , pp. 548-556
    • PATEL, N.C.1    CRISMON, M.L.2    HOAGWOOD, K.3
  • 20
    • 33645737575 scopus 로고    scopus 로고
    • Trends in prescribing of antipsychotic medications for US children
    • COOPER WO, ARBOGAST PG, DING H et al.: Trends in prescribing of antipsychotic medications for US children. Ambul. Pediatr. (2006) 6:79-83.
    • (2006) Ambul. Pediatr , vol.6 , pp. 79-83
    • COOPER, W.O.1    ARBOGAST, P.G.2    DING, H.3
  • 21
    • 0031812858 scopus 로고    scopus 로고
    • Prevalence and patterns of psychotropic and anticonvulsant medication in use in children and adolescents referred to residential treatment
    • CONNOR DF, OZBAYRAK KR, HARRISON RJ et al.: Prevalence and patterns of psychotropic and anticonvulsant medication in use in children and adolescents referred to residential treatment. J. Am. Acad. Child Adolesc. Psychopharm. (1998) 8:27-38.
    • (1998) J. Am. Acad. Child Adolesc. Psychopharm , vol.8 , pp. 27-38
    • CONNOR, D.F.1    OZBAYRAK, K.R.2    HARRISON, R.J.3
  • 23
    • 1942469582 scopus 로고    scopus 로고
    • Regional variation and clinical indicators of antipsychotic use in residential treatment: A four-state comparison
    • RAWAL PH, LYONS JS, MACINTYRE JC, HUNTER JC: Regional variation and clinical indicators of antipsychotic use in residential treatment: a four-state comparison. J. Behav. Health Serv. Res. (2004) 31:178-188.
    • (2004) J. Behav. Health Serv. Res , vol.31 , pp. 178-188
    • RAWAL, P.H.1    LYONS, J.S.2    MACINTYRE, J.C.3    HUNTER, J.C.4
  • 24
    • 0035432299 scopus 로고    scopus 로고
    • Psychotropic medication in children: A study from the Netherlands
    • SCHIRM E, TOBI H, ZITO JM, DE JONG-VAN DEN BERG LT: Psychotropic medication in children: a study from the Netherlands. Pediatrics (2001) 108:E25.
    • (2001) Pediatrics , vol.108
    • SCHIRM, E.1    TOBI, H.2    ZITO, J.M.3    DE JONG-VAN, D.B.L.4
  • 25
    • 0031772964 scopus 로고    scopus 로고
    • Antipsychotic drugs for non-psychotic patients: Assessment of the benefit/risk ratio in generalised anxiety disorder
    • EL-KHAYAT R, BALDWIN DS: Antipsychotic drugs for non-psychotic patients: assessment of the benefit/risk ratio in generalised anxiety disorder. J. Psychopharmacol. (1998) 12(4):323-329.
    • (1998) J. Psychopharmacol , vol.12 , Issue.4 , pp. 323-329
    • EL-KHAYAT, R.1    BALDWIN, D.S.2
  • 26
    • 27644534854 scopus 로고    scopus 로고
    • Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology
    • BALDWIN DS, ANDERSON IM, NUTT DJ et al.: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. (2005) 19:567-596.
    • (2005) J. Psychopharmacol , vol.19 , pp. 567-596
    • BALDWIN, D.S.1    ANDERSON, I.M.2    NUTT, D.J.3
  • 27
    • 0022610150 scopus 로고
    • Effective short-term treatment of anxiety: A double-blind trial
    • MENDELS J, KRAJEWSKI TF, HUFFER V: Effective short-term treatment of anxiety: a double-blind trial. J. Clin. Psychiatry (1986) 47:170-174.
    • (1986) J. Clin. Psychiatry , vol.47 , pp. 170-174
    • MENDELS, J.1    KRAJEWSKI, T.F.2    HUFFER, V.3
  • 28
    • 33750063164 scopus 로고    scopus 로고
    • Efficacy of typical and a typical antipsychotics for primary and comorbid anxiety symptoms or disorders: A review
    • GAO K, MUZINA D, GAJWANI P, CALABRESE JR: Efficacy of typical and a typical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J. Clin. Psychiatry (2006) 67:1327-1340.
    • (2006) J. Clin. Psychiatry , vol.67 , pp. 1327-1340
    • GAO, K.1    MUZINA, D.2    GAJWANI, P.3    CALABRESE, J.R.4
  • 29
    • 32144450616 scopus 로고    scopus 로고
    • Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: A placebo controlled study
    • POLLACK MH, SIMON NM, ZALTA AK: Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol. Psychiatry (2006) 59:211-215.
    • (2006) Biol. Psychiatry , vol.59 , pp. 211-215
    • POLLACK, M.H.1    SIMON, N.M.2    ZALTA, A.K.3
  • 30
    • 39749176354 scopus 로고    scopus 로고
    • Adjunctive risperidone in generalized anxiety disorder: A double-blind placebo-controlled study
    • BRAWMAN-MINTZER O, KNAPP RG, NIETERT PJ: Adjunctive risperidone in generalized anxiety disorder: a double-blind placebo-controlled study. J. Clin. Psychiatry (2006) 67:1307-1308.
    • (2006) J. Clin. Psychiatry , vol.67 , pp. 1307-1308
    • BRAWMAN-MINTZER, O.1    KNAPP, R.G.2    NIETERT, P.J.3
  • 31
  • 32
    • 33645233540 scopus 로고    scopus 로고
    • A review of antipsychotics in the treatment of obsessive compulsive disorder
    • FINEBERG NA, GALE TM, SIVAKUMARAN T: A review of antipsychotics in the treatment of obsessive compulsive disorder. J. Psychopharmacol. (2006) 20(1):97-103.
    • (2006) J. Psychopharmacol , vol.20 , Issue.1 , pp. 97-103
    • FINEBERG, N.A.1    GALE, T.M.2    SIVAKUMARAN, T.3
  • 33
    • 33751172334 scopus 로고    scopus 로고
    • Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: A meta-analysis of the randomized controlled trials
    • SKAPINAKIS P, PAPATHEODOROU T, MAVREAS V: Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur. Neuropsychopharmacol. (2006) 17:79-93.
    • (2006) Eur. Neuropsychopharmacol , vol.17 , pp. 79-93
    • SKAPINAKIS, P.1    PAPATHEODOROU, T.2    MAVREAS, V.3
  • 35
    • 0037239597 scopus 로고    scopus 로고
    • Antipsychotic augmentation for treatment-resistant obsessive compulsive disorder
    • MAINA G, ALBERT U, ZIERO S. BOGETTO F: Antipsychotic augmentation for treatment-resistant obsessive compulsive disorder. Int. Clin. Psychopharmacol. (2003) 18:23-28.
    • (2003) Int. Clin. Psychopharmacol , vol.18 , pp. 23-28
    • MAINA, G.1    ALBERT, U.2    ZIERO, S.3    BOGETTO, F.4
  • 36
    • 42749098607 scopus 로고    scopus 로고
    • Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
    • CD005473
    • IPSER JC, CAREY P, DHANSAY Y et al.: Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst. Rev. (2006) 4:CD005473.
    • (2006) Cochrane Database Syst. Rev , vol.4
    • IPSER, J.C.1    CAREY, P.2    DHANSAY, Y.3
  • 37
    • 84904507502 scopus 로고    scopus 로고
    • Posttraumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care
    • NATIONAL COLLABORATING CENTRE FOR MENTAL HEALTH:, Gaskell and British Psychological Society
    • NATIONAL COLLABORATING CENTRE FOR MENTAL HEALTH: Posttraumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care. National Clinical Practice Guideline Number 26. Gaskell and British Psychological Society (2005).
    • (2005) National Clinical Practice Guideline , Issue.26
  • 38
    • 39749194051 scopus 로고    scopus 로고
    • Review: Antidepressant plus antipsychotic increases clinical response rates in psychotic depression
    • CIPRIANI A, BARBUI C: Review: antidepressant plus antipsychotic increases clinical response rates in psychotic depression. Evid. Based Ment. Health (2007) 10:10.
    • (2007) Evid. Based Ment. Health , vol.10 , pp. 10
    • CIPRIANI, A.1    BARBUI, C.2
  • 40
    • 33744955788 scopus 로고    scopus 로고
    • Psychotic major depression a benefit: Risk assessment of treatment options
    • TYRKA AR, PRICE LH, MELLO MF, CARPENTER LL: Psychotic major depression a benefit: risk assessment of treatment options. Drug Saf. (2006) 29:491-508.
    • (2006) Drug Saf , vol.29 , pp. 491-508
    • TYRKA, A.R.1    PRICE, L.H.2    MELLO, M.F.3    CARPENTER, L.L.4
  • 42
    • 39749131091 scopus 로고    scopus 로고
    • NATIONAL INSTITUTE FOR HEALTH AND EXCELLENCE: Clinical Guideline 23. Depression. Management of Depression in Primary and Secondary Care. HMSO London, UK (2004).
    • NATIONAL INSTITUTE FOR HEALTH AND EXCELLENCE: Clinical Guideline 23. Depression. Management of Depression in Primary and Secondary Care. HMSO London, UK (2004).
  • 43
    • 0034059513 scopus 로고    scopus 로고
    • Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines
    • ANDERSON IM, NUTT DJ, DEAKIN JRW: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J. Psychopharmacol. (2000) 14:3-20.
    • (2000) J. Psychopharmacol , vol.14 , pp. 3-20
    • ANDERSON, I.M.1    NUTT, D.J.2    DEAKIN, J.R.W.3
  • 44
    • 28844471630 scopus 로고    scopus 로고
    • Typical and atypical antipsychotics in bipolar depression
    • GAO K, GAJWANI P, ELHAJ O, CALABRESE JR: Typical and atypical antipsychotics in bipolar depression. J. Clin. Psychiatry (2005) 66:1376-1385.
    • (2005) J. Clin. Psychiatry , vol.66 , pp. 1376-1385
    • GAO, K.1    GAJWANI, P.2    ELHAJ, O.3    CALABRESE, J.R.4
  • 45
    • 1842556548 scopus 로고    scopus 로고
    • The role of atypical antipsychotics in bipolar depression and anxiety disorders
    • MCINTYRE R, KATZMAN M: The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar. Disord. (2003) 5(S2):20-35.
    • (2003) Bipolar. Disord , vol.5 , Issue.S2 , pp. 20-35
    • MCINTYRE, R.1    KATZMAN, M.2
  • 46
    • 15744400568 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
    • CALABRESE JR, KEEK PE, MACFADDEN W et al.: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry (2005) 162:1351-1360.
    • (2005) Am. J. Psychiatry , vol.162 , pp. 1351-1360
    • CALABRESE, J.R.1    KEEK, P.E.2    MACFADDEN, W.3
  • 47
    • 33751116553 scopus 로고    scopus 로고
    • Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind placebo-controlled study (The BOLDER II Study)
    • THASE ME, MACFADDEN W, WEISLER RH et al.: Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind placebo-controlled study (The BOLDER II Study). J. Clin. Psychopharmacol. (2006) 26:600-609.
    • (2006) J. Clin. Psychopharmacol , vol.26 , pp. 600-609
    • THASE, M.E.1    MACFADDEN, W.2    WEISLER, R.H.3
  • 48
    • 29344438594 scopus 로고    scopus 로고
    • Use of atypical antipsychotics in refractory depression and anxiety
    • NEMEROFF CB: Use of atypical antipsychotics in refractory depression and anxiety. J. Clin. Psychiatry (2005) 66(Suppl. 8): 13-21.
    • (2005) J. Clin. Psychiatry , vol.66 , Issue.SUPPL. 8 , pp. 13-21
    • NEMEROFF, C.B.1
  • 49
    • 29444447124 scopus 로고    scopus 로고
    • Therapeutic options in the treatment of insomnia
    • ERMAN MK: Therapeutic options in the treatment of insomnia. J. Clin. Psychiatry (2005) 66(Suppl. 9):18-23.
    • (2005) J. Clin. Psychiatry , vol.66 , Issue.SUPPL. 9 , pp. 18-23
    • ERMAN, M.K.1
  • 50
    • 33744907790 scopus 로고    scopus 로고
    • National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
    • OLFSON M, BLANCO C, LIU L, MORENO C, LAJE G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch. Gen. Psychiatry (2006) 63:679-685.
    • (2006) Arch. Gen. Psychiatry , vol.63 , pp. 679-685
    • OLFSON, M.1    BLANCO, C.2    LIU, L.3    MORENO, C.4    LAJE, G.5
  • 51
    • 25844472161 scopus 로고    scopus 로고
    • Metabolic side effects of atypical antipsychotics in children: A literature review
    • FEDOROWICZ VJ, FOMBONNE E: Metabolic side effects of atypical antipsychotics in children: a literature review. J. Psychophamacol. (2005) 19:533-550.
    • (2005) J. Psychophamacol , vol.19 , pp. 533-550
    • FEDOROWICZ, V.J.1    FOMBONNE, E.2
  • 52
    • 21744441492 scopus 로고    scopus 로고
    • Treatment of psychosis in elderly people
    • KARIM S, BYRNE EJ: Treatment of psychosis in elderly people. Adv. Psych. Treatment (2005) 11:286-296.
    • (2005) Adv. Psych. Treatment , vol.11 , pp. 286-296
    • KARIM, S.1    BYRNE, E.J.2
  • 53
    • 26844538114 scopus 로고    scopus 로고
    • Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials
    • SCHNEIDER LS, DAGERMAN KS, INSEL P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. J. Am. Med. Assoc. (2005) 294:1934-1943.
    • (2005) J. Am. Med. Assoc , vol.294 , pp. 1934-1943
    • SCHNEIDER, L.S.1    DAGERMAN, K.S.2    INSEL, P.3
  • 54
    • 2542428510 scopus 로고    scopus 로고
    • CSM warning on atypical psychotics and stroke may be detrimental for dementia
    • MOWAT D, FOWLIE D: CSM warning on atypical psychotics and stroke may be detrimental for dementia. BMJ (2004) 328:1262.
    • (2004) BMJ , vol.328 , pp. 1262
    • MOWAT, D.1    FOWLIE, D.2
  • 55
    • 20044375721 scopus 로고    scopus 로고
    • Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study
    • GILL SS, ROCHON PA, HERRMANN N et al.: Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 330:445-450.
    • (2005) BMJ , vol.330 , pp. 445-450
    • GILL, S.S.1    ROCHON, P.A.2    HERRMANN, N.3
  • 56
    • 34249660551 scopus 로고    scopus 로고
    • All-cause mortality associated with typical and atypical antipsychotics in demented outpatients
    • TRIFIRÒ G, VERHAMME KMC, ZIERE G et al.: All-cause mortality associated with typical and atypical antipsychotics in demented outpatients. Pharmacoepidemiol. Drug Saf. (2007) 16:538-544.
    • (2007) Pharmacoepidemiol. Drug Saf , vol.16 , pp. 538-544
    • TRIFIRÒ, G.1    VERHAMME, K.M.C.2    ZIERE, G.3
  • 57
    • 28244431743 scopus 로고    scopus 로고
    • Risk of death in elderly users of conventional vs. atypical antipsychotic medications
    • WANG PS, SCHNEEWEISS S, AVORN J et al.: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N. Engl. J. Med. (2005) 353:2335-2341.
    • (2005) N. Engl. J. Med , vol.353 , pp. 2335-2341
    • WANG, P.S.1    SCHNEEWEISS, S.2    AVORN, J.3
  • 58
    • 34250631300 scopus 로고    scopus 로고
    • Antipsychotic drug use and mortality in older adults with dementia
    • GILL SS, BRONSKILL SE, NORMAND SLT et al.: Antipsychotic drug use and mortality in older adults with dementia. Ann. Intern. Med. (2007) 146:775-786.
    • (2007) Ann. Intern. Med , vol.146 , pp. 775-786
    • GILL, S.S.1    BRONSKILL, S.E.2    NORMAND, S.L.T.3
  • 59
    • 0033595555 scopus 로고    scopus 로고
    • A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia
    • DE DEYN PP, RABHERU K, RASMUSSEN A et al.: A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia. Neurology (1999) 53:946-955.
    • (1999) Neurology , vol.53 , pp. 946-955
    • DE DEYN, P.P.1    RABHERU, K.2    RASMUSSEN, A.3
  • 60
    • 0032966714 scopus 로고    scopus 로고
    • Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia
    • KATZ IR, JESTE DV, MINTZER JE, et al.: Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia. J. Clin. Psychiatry (1999) 60:107-115.
    • (1999) J. Clin. Psychiatry , vol.60 , pp. 107-115
    • KATZ, I.R.1    JESTE, D.V.2    MINTZER, J.E.3
  • 61
    • 0033799993 scopus 로고    scopus 로고
    • Olanzapine treatment for psychotics and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: A double blind, randomized, placebo-controlled trial: the HGEU Study Group
    • STREET JS, CLARK WS, GANNON KS et al.: Olanzapine treatment for psychotics and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities: a double blind, randomized, placebo-controlled trial: the HGEU Study Group. Arch. Gen. Psychiatry (2000) 57:968-976.
    • (2000) Arch. Gen. Psychiatry , vol.57 , pp. 968-976
    • STREET, J.S.1    CLARK, W.S.2    GANNON, K.S.3
  • 62
    • 0035674311 scopus 로고    scopus 로고
    • A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients
    • CHAN WC, LAM LC, CHOY CN: A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int. J. Geriatr. Psychiatry (2001) 16:1156-1162.
    • (2001) Int. J. Geriatr. Psychiatry , vol.16 , pp. 1156-1162
    • CHAN, W.C.1    LAM, L.C.2    CHOY, C.N.3
  • 63
    • 0037328229 scopus 로고    scopus 로고
    • A randomized placebo-controlled trial of risperidone for the treatment of agitation, aggression and psychosis of dementia
    • BRODATY H, AMES D, SNOWDON J: A randomized placebo-controlled trial of risperidone for the treatment of agitation, aggression and psychosis of dementia. J. Clin. Psychiatry (2003) 64:134-143.
    • (2003) J. Clin. Psychiatry , vol.64 , pp. 134-143
    • BRODATY, H.1    AMES, D.2    SNOWDON, J.3
  • 64
    • 33749618085 scopus 로고    scopus 로고
    • Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
    • SCHNEIDER IS, TARIOT PN, DAGERMAN KSL et al.: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N. Engl. J. Med. (2006) 355:1525-1538.
    • (2006) N. Engl. J. Med , vol.355 , pp. 1525-1538
    • SCHNEIDER, I.S.1    TARIOT, P.N.2    DAGERMAN, K.S.L.3
  • 65
    • 4544335523 scopus 로고    scopus 로고
    • Drug treatment for personality disorders
    • TYRER P, BATEMAN AW: Drug treatment for personality disorders. Advan. Psychiatr. Treat. (2004) 10:389-398.
    • (2004) Advan. Psychiatr. Treat , vol.10 , pp. 389-398
    • TYRER, P.1    BATEMAN, A.W.2
  • 66
    • 0020360014 scopus 로고
    • Pharmacological prevention of suicidal behaviour
    • MONTGOMERY SA, MONTGOMERY D: Pharmacological prevention of suicidal behaviour. J. Affect. Disord. (1982) 4:291-298.
    • (1982) J. Affect. Disord , vol.4 , pp. 291-298
    • MONTGOMERY, S.A.1    MONTGOMERY, D.2
  • 67
    • 85047697000 scopus 로고    scopus 로고
    • Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo controlled study
    • NICKEL MK, MUEHLBACHER M, NICKEL C et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo controlled study. Am. J. Psychiatry (2006) 163:833-838.
    • (2006) Am. J. Psychiatry , vol.163 , pp. 833-838
    • NICKEL, M.K.1    MUEHLBACHER, M.2    NICKEL, C.3
  • 68
    • 0038266769 scopus 로고    scopus 로고
    • Risperidone in the treatment of schizotypal personality disorder
    • KOENIGSBERG HW, REYNOLDS D, GOODMAN M et al.: Risperidone in the treatment of schizotypal personality disorder. J. Clin. Psychiatry (2003) 64:628-634.
    • (2003) J. Clin. Psychiatry , vol.64 , pp. 628-634
    • KOENIGSBERG, H.W.1    REYNOLDS, D.2    GOODMAN, M.3
  • 69
    • 33645515279 scopus 로고    scopus 로고
    • Pharmacological interventions for people with borderline personality disorder
    • BINKS CA, FENTON M, MCCARTHY L et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst. Rev. (2006) 1.
    • (2006) Cochrane Database Syst. Rev , pp. 1
    • BINKS, C.A.1    FENTON, M.2    MCCARTHY, L.3
  • 71
    • 0029072051 scopus 로고
    • Prescribing of potentially harmful drugs to patients admitted to hospital after head injury
    • GOLDSTEIN LB: Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J. Neurol. Neurosurg. Psychiatry (1995) 58:753-755.
    • (1995) J. Neurol. Neurosurg. Psychiatry , vol.58 , pp. 753-755
    • GOLDSTEIN, L.B.1
  • 72
    • 39049176339 scopus 로고    scopus 로고
    • Pharmacological management for agitation and aggression in people with acquired brain injury
    • CD003299
    • FLEMINGER S, GREENWOOD RJ, OLIVER DL: Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst. Rev. (2006), 4:CD003299.
    • (2006) Cochrane Database Syst. Rev , vol.4
    • FLEMINGER, S.1    GREENWOOD, R.J.2    OLIVER, D.L.3
  • 73
    • 0035138025 scopus 로고    scopus 로고
    • Methotrimeprazine in the treatment of agitation in acquired brain injury patients
    • MARYNIAK O, MANCHANDA R, VELANI A: Methotrimeprazine in the treatment of agitation in acquired brain injury patients. Brain Inj. (2001) 15:167-174.
    • (2001) Brain Inj , vol.15 , pp. 167-174
    • MARYNIAK, O.1    MANCHANDA, R.2    VELANI, A.3
  • 74
    • 0038045267 scopus 로고    scopus 로고
    • Managing agitation and aggression after head injury
    • FLEMINGER S: Managing agitation and aggression after head injury. BMJ (2003) 327:4-5.
    • (2003) BMJ , vol.327 , pp. 4-5
    • FLEMINGER, S.1
  • 75
    • 16544387381 scopus 로고    scopus 로고
    • Antipsychotic medication for challenging behaviour in people with learning disability
    • CD000377
    • BRYLEWSKI J, DUGGAN L: Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database Syst. Rev. (2004), 3:CD000377.
    • (2004) Cochrane Database Syst. Rev , vol.3
    • BRYLEWSKI, J.1    DUGGAN, L.2
  • 76
    • 11844269286 scopus 로고    scopus 로고
    • Withdrawal of antipsychotic drugs from adults with intellectual disabilities
    • STEVENSON C, RAJAN L, REID G et al.: Withdrawal of antipsychotic drugs from adults with intellectual disabilities. Ir. J. Psych. Med. (2004) 21:85-90.
    • (2004) Ir. J. Psych. Med , vol.21 , pp. 85-90
    • STEVENSON, C.1    RAJAN, L.2    REID, G.3
  • 77
    • 23944435978 scopus 로고    scopus 로고
    • Evidence-based practices in intellectual disability and behaviour disorders
    • GREY IM, HASTINGS RP: Evidence-based practices in intellectual disability and behaviour disorders. Curr. Opin. Psychiatry (2005) 18:469-475.
    • (2005) Curr. Opin. Psychiatry , vol.18 , pp. 469-475
    • GREY, I.M.1    HASTINGS, R.P.2
  • 81
    • 1942507400 scopus 로고    scopus 로고
    • The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder
    • KANT R, CHALANSANI R, CHENGAPPA RN, DIERINGER MF: The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J. Child Adolesc. Psychopharmacol. (2004) 14:57-63.
    • (2004) J. Child Adolesc. Psychopharmacol , vol.14 , pp. 57-63
    • KANT, R.1    CHALANSANI, R.2    CHENGAPPA, R.N.3    DIERINGER, M.F.4
  • 82
    • 0028348949 scopus 로고
    • The use of high-dose antipsychotic medication
    • THOMPSON C: The use of high-dose antipsychotic medication. Br. J. Psychiatry (1994) 164:448458.
    • (1994) Br. J. Psychiatry , vol.164 , pp. 448458
    • THOMPSON, C.1
  • 83
    • 0036849024 scopus 로고    scopus 로고
    • The results of a multi-centre audit of prescribing of antipsychotic drugs for inpatients in the UK
    • HARRINGTON M, LELLIOTT P, PATON C et al.: The results of a multi-centre audit of prescribing of antipsychotic drugs for inpatients in the UK. Psychiatr. Bull. (2002) 26:414-418.
    • (2002) Psychiatr. Bull , vol.26 , pp. 414-418
    • HARRINGTON, M.1    LELLIOTT, P.2    PATON, C.3
  • 84
    • 27744452819 scopus 로고    scopus 로고
    • Prescribing of antipsychotic medication in a Medicaid population: Use of polytherapy and off-label dosages
    • KOGUT SJ, YAM F, DUFRESNE R: Prescribing of antipsychotic medication in a Medicaid population: use of polytherapy and off-label dosages. J. Manag. Care Pharm. (2005) 11:17-24.
    • (2005) J. Manag. Care Pharm , vol.11 , pp. 17-24
    • KOGUT, S.J.1    YAM, F.2    DUFRESNE, R.3
  • 85
    • 3142700764 scopus 로고    scopus 로고
    • High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia psychotropic prescriptions) study
    • SIM K, SU A, LEONG JY et al.: High dose antipsychotic use in schizophrenia: findings of the REAP (Research on East Asia psychotropic prescriptions) study. Pharmacopsychiatry (2004) 37:175-179.
    • (2004) Pharmacopsychiatry , vol.37 , pp. 175-179
    • SIM, K.1    SU, A.2    LEONG, J.Y.3
  • 86
    • 39749185470 scopus 로고    scopus 로고
    • Dose form modification - a common but potentially hazardous practice. A literature review and a study of medication administration
    • In Press
    • STUBBS J, HAW C, DICKENS G: Dose form modification - a common but potentially hazardous practice. A literature review and a study of medication administration. Int. Psychogeriatr. (In Press).
    • Int. Psychogeriatr
    • STUBBS, J.1    HAW, C.2    DICKENS, G.3
  • 87
    • 0033968969 scopus 로고    scopus 로고
    • Antipsychotics - the future of schizophrenia treatment
    • BEAUMONT G: Antipsychotics - the future of schizophrenia treatment. Curr. Med. Res. Opin. (2000) 16(1):37-42.
    • (2000) Curr. Med. Res. Opin , vol.16 , Issue.1 , pp. 37-42
    • BEAUMONT, G.1
  • 88
    • 0024264554 scopus 로고
    • The role of neuroleptics in manic-depressive illness
    • KANE JM: The role of neuroleptics in manic-depressive illness. J. Clin. Psychiatry (1988) 49(Suppl.):12-14.
    • (1988) J. Clin. Psychiatry , vol.49 , Issue.SUPPL. , pp. 12-14
    • KANE, J.M.1
  • 89
    • 3042785965 scopus 로고    scopus 로고
    • Tardive dyskinesia rates with atypical antipsychotics in adults: Prevalence and incidence
    • KANE JM: Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J. Clin. Psychiatry (2004) 65(Suppl. 9): 16-20.
    • (2004) J. Clin. Psychiatry , vol.65 , Issue.SUPPL. 9 , pp. 16-20
    • KANE, J.M.1
  • 90
    • 24344449718 scopus 로고    scopus 로고
    • The safety and tolerability of atypical antipsychotics in bipolar disorder
    • SEEMULLER F, FORSTHOFF A, DITTMENN S et al.: The safety and tolerability of atypical antipsychotics in bipolar disorder. Expert Opin. Drug Saf. (2005) 4:849-868.
    • (2005) Expert Opin. Drug Saf , vol.4 , pp. 849-868
    • SEEMULLER, F.1    FORSTHOFF, A.2    DITTMENN, S.3
  • 91
    • 25444513136 scopus 로고    scopus 로고
    • Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: A systematic study of tolerability and use in different diagnostic groups
    • CURRAN S, TURNER D, MUSA S, WATTIS J: Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Int. J. Geriatr. Psychiatry (2005) 20:842-847.
    • (2005) Int. J. Geriatr. Psychiatry , vol.20 , pp. 842-847
    • CURRAN, S.1    TURNER, D.2    MUSA, S.3    WATTIS, J.4
  • 92
    • 1842739590 scopus 로고    scopus 로고
    • Adverse metabolic effects associated with atypical antipsychotics
    • MELKERSSON K, DAHL ML: Adverse metabolic effects associated with atypical antipsychotics. Drugs (2004) 64:701-723.
    • (2004) Drugs , vol.64 , pp. 701-723
    • MELKERSSON, K.1    DAHL, M.L.2
  • 93
    • 16644392426 scopus 로고    scopus 로고
    • Abnormalities of glucose metabolism associated with atypical antipsychotic drugs
    • NEWCOMER JW: Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J. Clin. Psychiatry (2004) 65(Suppl. 18):36-46.
    • (2004) J. Clin. Psychiatry , vol.65 , Issue.SUPPL. 18 , pp. 36-46
    • NEWCOMER, J.W.1
  • 94
    • 0034121256 scopus 로고    scopus 로고
    • Atypical antipsychotics and weight gain - a systematic review
    • TAYLOR DM, MCASKILL R: Atypical antipsychotics and weight gain - a systematic review. Acta Psych. Scand. 101:416-432.
    • Acta Psych. Scand , vol.101 , pp. 416-432
    • TAYLOR, D.M.1    MCASKILL, R.2
  • 95
    • 0037318271 scopus 로고    scopus 로고
    • Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY) pt 1: A review
    • SCHURR SB, SIKICH L, FINDLING RL et al.: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY) pt 1: a review. J. Am. Acad. Adolesc. Psychiatry (2003) 42:132-144.
    • (2003) J. Am. Acad. Adolesc. Psychiatry , vol.42 , pp. 132-144
    • SCHURR, S.B.1    SIKICH, L.2    FINDLING, R.L.3
  • 96
    • 0032958401 scopus 로고    scopus 로고
    • Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs
    • LEIPZIG RM, CUMMINGS RG, TINETTI ME: Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J. Am. Geriatr. Soc. (1999) 47(1):30-39.
    • (1999) J. Am. Geriatr. Soc , vol.47 , Issue.1 , pp. 30-39
    • LEIPZIG, R.M.1    CUMMINGS, R.G.2    TINETTI, M.E.3
  • 97
    • 25144510914 scopus 로고    scopus 로고
    • Atypical antipsychotic medications and risk of falls in residents of aged care facilities
    • HIEN LE TT, CUMMING RG, CAMERON ID et al.: Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J. Am. Geriatr. Soc. (2005) 53(8): 1290-1295.
    • (2005) J. Am. Geriatr. Soc , vol.53 , Issue.8 , pp. 1290-1295
    • HIEN, L.T.1    CUMMING, R.G.2    CAMERON, I.D.3
  • 99
    • 0034712552 scopus 로고    scopus 로고
    • QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
    • REILLY JG, AYIS SA, FERRIER IN, JONES SJ, THOMAS SH: QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet (2000) 355(9209):1048-1052.
    • (2000) Lancet , vol.355 , Issue.9209 , pp. 1048-1052
    • REILLY, J.G.1    AYIS, S.A.2    FERRIER, I.N.3    JONES, S.J.4    THOMAS, S.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.